Literature DB >> 10719846

Genomic changes and HPV type in cervical carcinoma.

C P Matthews1, K A Shera, J K McDougall.   

Abstract

To identify chromosomal regions that may include the loci of abnormally expressed cellular genes and may be specifically altered depending on the histological subtype of the tumor, we studied primary cervical carcinoma using CGH and HPV genotyping. Eighty-seven percent of the primary tumors were positive for DNA of a "high-risk" HPV type (e.g., 16 or 18). In the cervical carcinomas, without reference to histologic subtype, overrepresentation of chromosome 3q was the most consistent chromosomal aberration with underrepresentation of chromosome 3p also a frequent finding. Chromosome arms 1q, 5p, 20q, and Xq were overrepresented in many tumors and 3p loss and 5p, 8q, and 16q gain were only associated with squamous cell carcinoma in this series.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719846     DOI: 10.1046/j.1525-1373.2000.22345.x

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  11 in total

1.  Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.

Authors:  Sonia Andersson; Pavani Sowjanya; Darawalee Wangsa; Anders Hjerpe; Bo Johansson; Gert Auer; Patti E Gravitt; Catharina Larsson; Keng-Ling Wallin; Thomas Ried; Kerstin Heselmeyer-Haddad
Journal:  Am J Pathol       Date:  2009-11       Impact factor: 4.307

2.  Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.

Authors:  Kerstin Heselmeyer-Haddad; Kathrin Sommerfeld; Nicole M White; Nadia Chaudhri; Larry E Morrison; Nallasivam Palanisamy; Zhen Yuan Wang; Gert Auer; Winfried Steinberg; Thomas Ried
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

3.  Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.

Authors:  Wendy Theelen; Ernst-Jan M Speel; Michael Herfs; Martin Reijans; Guus Simons; Els V Meulemans; Marcella M Baldewijns; Frans C S Ramaekers; Joan Somja; Philippe Delvenne; Anton H N Hopman
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

4.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

5.  Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results.

Authors:  Patricia Luhn; Jane Houldsworth; Lynnette Cahill; Mark Schiffman; Philip E Castle; Rosemary E Zuna; S Terence Dunn; Michael A Gold; Joan Walker; Nicolas Wentzensen
Journal:  Gynecol Oncol       Date:  2013-06-13       Impact factor: 5.482

6.  Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens.

Authors:  Irina Sokolova; Alicia Algeciras-Schimnich; Minghao Song; Svetlana Sitailo; Frank Policht; Benjamin R Kipp; Jesse S Voss; Kevin C Halling; Adam Ruth; Walter King; Dawn Underwood; Jennifer Brainard; Larry Morrison
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

7.  Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1.

Authors:  Thomas Iftner; Michaela Elbel; Betti Schopp; Thomas Hiller; Joanna I Loizou; Keith W Caldecott; Frank Stubenrauch
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

8.  HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.

Authors:  Mariska Bierkens; Saskia M Wilting; Wessel N van Wieringen; Mark A van de Wiel; Bauke Ylstra; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen
Journal:  BMC Cancer       Date:  2012-01-24       Impact factor: 4.430

9.  Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.

Authors:  Oscar Vazquez-Mena; Ingrid Medina-Martinez; Eligia Juárez-Torres; Valeria Barrón; Ana Espinosa; Nicolás Villegas-Sepulveda; Laura Gómez-Laguna; Karem Nieto-Martínez; Lorena Orozco; Edgar Roman-Basaure; Sergio Muñoz Cortez; Manuel Borges Ibañez; Carlos Venegas-Vega; Mariano Guardado-Estrada; Angélica Rangel-López; Susana Kofman; Jaime Berumen
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

10.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Authors:  Judith N Kloth; Jan Oosting; Tom van Wezel; Karoly Szuhai; Jeroen Knijnenburg; Arko Gorter; Gemma G Kenter; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  BMC Genomics       Date:  2007-02-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.